Genomic variation in the MAP3K5 gene is associated with &bgr;-thalassemia disease severity and hydroxyurea treatment efficacy

Author: Tafrali Christina   Paizi Arsinoi   Borg Joseph   Radmilovic Milena   Bartsakoulia Marina   Giannopoulou Emily   Giannakopoulou Olga   Stojiljkovic-Petrovic Maja   Zukic Branka   Poulas Konstantinos   Stavrou Eleana F   Lambropoulou Polyxeni   Kourakli Alexandra   Felice Alexander E   Papachatzopoulou Adamantia   Philipsen Sjaak   Pavlovic Sonja   Georgitsi Marianthi   Patrinos George P  

Publisher: Future Medicine

ISSN: 1462-2416

Source: Pharmacogenomics, Vol.14, Iss.5, 2013-04, pp. : 469-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content